Growth hormone-releasing hormone antagonists abolish the transactivation of human epidermal growth factor receptors in advanced prostate cancer models

  1. Muñoz-Moreno, L.
  2. Arenas, M.I.
  3. Carmena, M.J.
  4. Schally, A.V.
  5. Prieto, J.C.
  6. Bajo, A.M.
Journal:
Investigational New Drugs

ISSN: 1573-0646,  0167-6997

Year of publication: 2014

Volume: 32

Issue: 5

Pages: 871-882

Type: Article

DOI: 10.1007/S10637-014-0131-4 GOOGLE SCHOLAR

Sustainable development goals

Data source: Scopus